Carnegie Investment Counsel Boosts Position in The Allstate Co. (NYSE:ALL)

Carnegie Investment Counsel boosted its holdings in shares of The Allstate Co. (NYSE:ALL) by 116.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,562 shares of the insurance provider’s stock after buying an additional 1,381 shares during the quarter. Carnegie Investment Counsel’s holdings in Allstate were worth $494,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ALL. Pathway Financial Advisers LLC raised its position in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after buying an additional 1,047,019 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after buying an additional 472,040 shares during the last quarter. AQR Capital Management LLC raised its position in Allstate by 181.6% during the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock worth $114,955,000 after buying an additional 464,337 shares during the last quarter. TimesSquare Capital Management LLC purchased a new position in Allstate during the 3rd quarter worth approximately $77,819,000. Finally, Los Angeles Capital Management LLC raised its position in Allstate by 688.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider’s stock worth $87,292,000 after buying an additional 401,901 shares during the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Stock Down 1.2 %

NYSE ALL opened at $188.85 on Friday. The Allstate Co. has a 52 week low of $150.17 and a 52 week high of $209.88. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The business’s fifty day simple moving average is $195.73 and its 200-day simple moving average is $186.32. The firm has a market cap of $50.01 billion, a PE ratio of 12.23, a P/E/G ratio of 1.35 and a beta of 0.52.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the previous year, the firm earned $0.81 EPS. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. As a group, equities analysts anticipate that The Allstate Co. will post 16.45 earnings per share for the current year.

Allstate Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were issued a dividend of $0.92 per share. The ex-dividend date was Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.95%. Allstate’s dividend payout ratio is presently 23.83%.

Analysts Set New Price Targets

Several research firms have recently weighed in on ALL. JPMorgan Chase & Co. lifted their target price on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a report on Thursday, October 10th. Keefe, Bruyette & Woods lifted their price target on shares of Allstate from $235.00 to $243.00 and gave the company an “outperform” rating in a research note on Friday, January 10th. Raymond James lifted their price target on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Wells Fargo & Company lifted their price target on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Finally, Barclays dropped their price target on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating on the stock in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $218.13.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.